Swastik Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.40 M
as on 02-07-2024
- Paid Up Capital ₹ 1.12 M
as on 02-07-2024
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.91 M
as on 02-07-2024
- Satisfied Charges ₹ 44.48 M
as on 02-07-2024
- Revenue 263.34%
(FY 2022)
- Profit -87.18%
(FY 2022)
- Ebitda -221.47%
(FY 2022)
- Net Worth -13.37%
(FY 2022)
- Total Assets 108.45%
(FY 2022)
About Swastik Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.40 M and a paid-up capital of Rs 1.12 M.
The company currently has active open charges totaling ₹0.91 M. The company has closed loans amounting to ₹4.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Raniga, Pallavi Raniga, and Sadhana Pandey serve as directors at the Company.
- CIN/LLPIN
U24231UP1989PTC010662
- Company No.
010662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 1989
- Date of AGM
21 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Uttar Pradesh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Swastik Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Raniga  | Director | 12-Dec-2018 | Current |
| Manish Raniga | Director | 22-Oct-2020 | Current |
| Sadhana Pandey | Director | 12-Apr-1989 | Current |
Financial Performance and Corporate Structure Insights of Swastik Formulations.
Swastik Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 263.34% increase. The company also saw a substantial fall in profitability, with a 87.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swastik Formulations?
In 2021, Swastik Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Varuna Herbo Biotec Private Limited
Active
35 years 8 days Manish Raniga, Pallavi Raniga and 1 more are mutual person
Varuna Biocell Private Limited
Active 25 years 3 months Pallavi Raniga and Sadhana Pandey are mutual person
Pandey Leasing Private Limited
Active 33 years 3 months Manish Raniga, Pallavi Raniga and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Jul 2021 | ₹0.91 M | Open |
Canara Bank Creation Date: 13 Feb 2010 | ₹8.46 M | Satisfied |
Canara Bank Creation Date: 06 Feb 1998 | ₹2.00 M | Satisfied |
How Many Employees Work at Swastik Formulations?
Swastik Formulations has a workforce of 65 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swastik Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swastik Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
